Frontlight ResearchEarly access
Melanoma trials in Russia
3 of 4 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 4Active, not recruitingDabrafenib and/or Trametinib Rollover Study
- Where
- Moscow
- Age
- 18 years to 100 years
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - Phase 1/2TerminatedBI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Where
- Omsk, Saint Petersburg
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- BioInvent International AB
See details and how to joinNCT04752826 · EU 2023-509847-29-00 - Phase 2Taking peopleEfficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade
- Where
- Saint Petersburg
- Age
- 18 years and over
- People
- 90
- Run by
- EuroCityClinic LLC
See details and how to joinNCT07130032